Clinical Trials Directory

Trials / Completed

CompletedNCT01852006

Abdominal Binding in Chronic Obstructive Pulmonary Disease

Abdominal Binding: a Novel Intervention to Relieve Dyspnea and Improve Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
McGill University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Conventional approaches to relieve dyspnea (respiratory discomfort) in chronic obstructive pulmonary disease (COPD) have focused on improving respiratory motor drive (e.g., hyperoxia) and/or dynamic respiratory mechanics (e.g., bronchodilators). Although these approaches yield meaningful symptom improvements there remains many COPD patients incapacitated by dyspnea. Accumulating evidence suggests that abdominal binding (AB) is a potentially novel method of improving respiratory muscle function and, by extension, dyspnea and exercise tolerance in COPD. Thus, the purpose of this randomized, cross-over study is to test the hypothesis that AB improves exertional dyspnea and exercise tolerance in symptomatic patients with COPD by improving dynamic respiratory muscle function. To this end, the investigators will examine the effects of AB on detailed assessments of baseline pulmonary function (spirometry, plethysmography), dyspnea (sensory intensity \& affective responses), neural respiratory drive (diaphragm EMG), contractile respiratory muscle function (esophageal, gastric \& transdiaphragmatic pressures), ventilation, breathing pattern and cardiometabolic function during symptom-limited constant load cycle exercise (75% Wmax) in 20 patients with GOLD stage II/III COPD.

Conditions

Interventions

TypeNameDescription
DEVICEAbdominal BinderAbdominal Binding to increase end-expiratory gastric pressure by 5-8 centimetres of water at rest.

Timeline

Start date
2014-01-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2013-05-13
Last updated
2015-08-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01852006. Inclusion in this directory is not an endorsement.